Scarica l'app Stockscreener
3.61
2.27%
0.08
Dopo l'orario di chiusura:
3.61
Grace Therapeutics Inc Borsa (GRCE) Ultime notizie
Does Grace Therapeutics Inc. have a sustainable dividend2025 Volume Leaders & Real-Time Volume Surge Alerts - mfd.ru
Is SFYX stock good for wealth creationVolume Spike & Capital Efficiency Focused Ideas - mfd.ru
Analysts Are Bullish on Top Healthcare Stocks: Grace Therapeutics (GRCE), Alto Neuroscience, Inc. (ANRO) - The Globe and Mail
Is Grace Therapeutics Inc. still a buy after recent gainsWeekly Trading Summary & Technical Pattern Alert System - mfd.ru
Market Catalysts: What is Grace Therapeutics Incs valuation compared to sectorInsider Buying & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Grace Therapeutics announces third quarter 2026 financial results, provides business update - marketscreener.com
Grace Therapeutics (NASDAQ:GRCE) Announces Earnings Results - MarketBeat
Grace Therapeutics (GRCE) Advances Towards FDA Review with Promi - GuruFocus
Is Grace Therapeutics Inc. a cyclical or defensive stockWeekly Stock Summary & Accurate Trade Setup Notifications - mfd.ru
Grace: Fiscal Third Quarter Earnings Overview - Bitget
Grace: Fiscal Q3 Earnings Snapshot - kare11.com
Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update - The Manila Times
Grace Therapeutics Q3 2026 Financial Results and Business Update - TradingView
April 23 FDA target date set for Grace’s GTx-104 aSAH drug - Stock Titan
Grace Therapeutics, Inc. SEC 10-Q Report - TradingView
Moderna | History, Innovation, Challenges, & Facts - Britannica
Aug Selloffs: What are the risks of holding BioXcel Therapeutics Inc.Weekly Volume Report & Consistent Growth Stock Picks - mfd.ru
Grace Therapeutics (GRCE) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Volatility Watch: Can SolarBank Corporation generate free cash flowJuly 2025 Opening Moves & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Aug Fed Impact: Why is Grace Therapeutics Inc stock going upMarket Trend Review & Smart Allocation Stock Tips - baoquankhu1.vn
Big Money Moves: Can Tower Semiconductor Ltd weather a recessionQuarterly Trade Report & AI Powered Market Entry Ideas - baoquankhu1.vn
Quarterly Recap: Does IMMR stock benefit from AI growthMarket Growth Review & Fast Momentum Entry Tips - baoquankhu1.vn
Gainers Report: Can Grace Therapeutics Inc weather a recessionTake Profit & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Grace Therapeutics, Inc. (NASDAQ:GRCE) Short Interest Up 34.6% in January - MarketBeat
Dividend Watch: Is ETRACS 2xMonthly Pay Leveraged Index ETN benefiting from interest rate changesMarket Risk Report & Capital Protection Trade Alerts - baoquankhu1.vn
New Highs: Is Grupo Supervielle SA Depositary Receipt a strong candidate for buy and holdJuly 2025 News Drivers & Stepwise Trade Execution Plans - baoquankhu1.vn
What is Chicago Atlantic Real Estate Finance Inc. s 5 year growth outlookJuly 2025 Selloffs & Stepwise Trade Execution Plans - mfd.ru
P 500July 2025 Patterns & Stepwise Entry and Exit Trade Signals - mfd.ru
Chart Watch: Will XPON outperform small cap indexesIndex Update & Weekly Breakout Watchlists - baoquankhu1.vn
Why APYX stock attracts strong analyst attention - baoquankhu1.vn
Trading Recap: Will Bullfrog AI Holdings Inc Equity Warrant stock recover after earningsQuarterly Profit Report & Real-Time Volume Spike Alerts - baoquankhu1.vn
Update Recap: Why is Grace Therapeutics Inc stock going up2025 Trade Ideas & Safe Entry Zone Tips - baoquankhu1.vn
Bull Bear: Does Grace Therapeutics Inc have a sustainable dividendJuly 2025 PreEarnings & High Return Stock Watch Alerts - baoquankhu1.vn
Grace Therapeutics (NASDAQ:GRCE) vs. Adhera Therapeutics (OTCMKTS:ATRX) Financial Review - Defense World
WESCO International, Inc. (NYSE:WCC) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Grace Therapeutics (NASDAQ:GRCE) Stock Rating Upgraded by Wall Street Zen - Defense World
Published on: 2026-01-25 20:15:18 - baoquankhu1.vn
AIGH Capital Management LLC Sells 221,280 Shares of Grace Therapeutics, Inc. $GRCE - Defense World
Ovintiv Inc. (TSE:OVV) Receives Average Rating of “Buy” from Analysts - Defense World
Big Picture: Is Amcor plc a strong growth stockPortfolio Update Report & Expert Verified Movement Alerts - baoquankhu1.vn
Ten new option listings and two option delistings on January 22nd - TipRanks
What’s Grace Therapeutics Inc.’s historical returnAnalyst Upgrades & Free Superior Profit Margins - Bollywood Helpline
Why Grace Therapeutics Inc. stock remains a top recommendationSupport Level Holds & Superior Capital Trading - Bollywood Helpline
Is Grace Therapeutics Inc benefiting from interest rate changes2025 Volatility Report & Daily Stock Trend Reports - baoquankhu1.vn
Grace Therapeutics, Inc. (NASDAQ:GRCE) Sees Significant Increase in Short Interest - MarketBeat
Earnings Risk: Should you avoid XPeng Inc Depositary Receipt stock right nowTrade Exit Summary & Daily Chart Pattern Signals - baoquankhu1.vn
Stock Report: What are the future prospects of BMBLTrade Risk Summary & Weekly Market Pulse Alerts - baoquankhu1.vn
Aug Technicals: Can Grace Therapeutics Inc maintain sales growth2025 Analyst Calls & Short-Term High Return Ideas - baoquankhu1.vn
• Diversification across cement stocks recommendedMarket Liquidity Analysis & Big Gains Low Cost - bollywoodhelpline.com
CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm - The Malaysian Reserve
Can Grace Therapeutics Inc. weather a recessionRate Cut & Safe Capital Growth Trade Ideas - bollywoodhelpline.com
Market Review: Why is Grace Therapeutics Inc stock going up2025 Year in Review & Verified Technical Signals - baoquankhu1.vn
Grace Therapeutics Enhances Executive Severance and Change‑in‑Control Terms - The Globe and Mail
Rally Mode: Is MOG.B a defensive stock2025 Volume Leaders & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Grace Therapeutics updates executive severance terms following contract amendments By Investing.com - Investing.com Australia
Grace Therapeutics updates executive severance terms following contract amendments - Investing.com
Grace Therapeutics secures up to $30 million financing - MSN
Grace Therapeutics reports positive Phase 3 trial results for GTx-104 - MSN
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):